.Pharmacolibrary.Drugs.R_RespiratorySystem.R05C_ExpectorantsExclCombinationsWithCoughSuppressant.R05CA08_Creosote.Creosote .Pharmacolibrary.Drugs.R_RespiratorySystem.R05C_ExpectorantsExclCombinationsWithCoughSuppressant.R05CA08_Creosote.Creosote| name: | Creosote | |
| ATC code: | R05CA08 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 30 | L |
| clearance: | 2 | L/h |
| other parameters in model implementation | ||
Creosote is a complex mixture of phenolic compounds derived from the distillation of tar, primarily used historically as a disinfectant, expectorant, and externally as an antiseptic. It was formerly indicated for cough and respiratory tract diseases but is no longer approved as a therapeutic drug due to its toxicity and carcinogenic potential.
No published human pharmacokinetic studies or clinical PK models specifically for creosote are available. Estimated parameters provided below refer to a hypothetical adult oral administration in the absence of referenced data.